B-type natriuretic peptide–guided management and outcome in patients with obesity and dyspnea—Results from the BASEL study
- 30 September 2009
- journal article
- research article
- Published by Elsevier BV in American Heart Journal
- Vol. 158 (3), 488-495
- https://doi.org/10.1016/j.ahj.2009.05.033
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Impact of Body Mass Index on Outcomes After Percutaneous Coronary Intervention in Patients With Acute Myocardial InfarctionThe American Journal of Cardiology, 2007
- How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure: Results from the Breathing Not Properly Multinational StudyAmerican Heart Journal, 2006
- Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: A ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudyAmerican Heart Journal, 2005
- Use of B-Type Natriuretic Peptide in the Evaluation and Management of Acute DyspneaNew England Journal of Medicine, 2004
- Body-Mass Index and Mortality in a Prospective Cohort of U.S. AdultsNew England Journal of Medicine, 1999
- Wasting as independent risk factor for mortality in chronic heart failureThe Lancet, 1997
- Salt-regulating hormones in young normotensive obese subjects. Effects of saline load.Hypertension, 1994
- Considerations in the use of echocardiography in epidemiology. The Framingham Study.Hypertension, 1987
- Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study.Cell Metabolism, 1983
- Borderline hypertension and obesity: two prehypertensive states with elevated cardiac output.Cell Metabolism, 1982